RecruitingNCT00414115

National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children

Canadian Pharmacogenomics Network for Drug Safety


Sponsor

University of British Columbia

Enrollment

7,000 participants

Start Date

Aug 1, 2005

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the study is (1) to identify and collect samples from children and adults who take drugs and have adverse drug reactions AND children and adults who take drugs and do not experience any adverse drug effects; (2) to determine if genetic differences between the two groups contribute to causing the adverse drug reactions; and (3) to develop patient specific drug dosing guidelines to prevent future adverse drug reactions. We also wish to compare the use of prescription drugs, medical and hospital services and vital statistics between BC participants who experience adverse drug reactions and those who do not. Study hypothesis: Genetic differences may contribute to patients' response to drugs and may be responsible for adverse drug reactions.


Eligibility

Inclusion Criteria4

  • Children under 19 years who have taken drugs.
  • Biological parents of children who have had an ADR.
  • Patients/parents who speak and understand English (except in Quebec).
  • Adults (for validation of findings in children)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Children's and Women's Health Centre of British Columbia

Vancouver, British Columbia, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00414115


Related Trials